Company Filing History:
2 out of 2 
2 out of 6 
2 out of 1,039 
Years Active: 2000-2009
Title: Biography of Inventor Mark Froimowitz
Introduction: Mark Froimowitz is a notable inventor based in Newton Centre, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases characterized by unwanted cellular proliferation.
Latest Patents: Froimowitz holds five patents, with his latest inventions focusing on the use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseases. This invention provides a class of chemical compounds that serve as efficacious drugs in the treatment of sickle cell disease and other conditions characterized by abnormal cell proliferation. The active compounds include substituted triaryl methane compounds or analogues, which can inhibit mammalian cell proliferation and delay the occurrence of erythrocyte sickling.
Career Highlights: Throughout his career, Froimowitz has worked with several prominent companies, including Ion Pharmaceuticals, Inc. and Biofrontera Bioscience GmbH. His work has been instrumental in advancing therapeutic options for patients suffering from various inflammatory diseases.
Collaborations: Froimowitz has collaborated with esteemed colleagues such as Carlo Brugnara and Jose Alberto Halperin. These partnerships have contributed to the development of innovative solutions in the pharmaceutical industry.
Conclusion: Mark Froimowitz's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving health outcomes. His work continues to influence the development of new treatments